PubMed:24281730 / 572-883 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T6","span":{"begin":0,"end":311},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":311},"obj":"Sentence"}],"text":"We conducted a 32-week, double-blind, placebo-controlled, cross-over and randomized trial that implicated two arms: arm A, 20 patients received levocetirizine, montelukast with or without levocetirizine or placebo; arm B, 20 patients received desloratadine, montelukast with or without desloratadine or placebo."}

{"project":"luoyt2021_800_3","denotations":[{"id":"T6","span":{"begin":258,"end":269},"obj":"CI"},{"id":"T7","span":{"begin":160,"end":171},"obj":"CI"},{"id":"T25","span":{"begin":144,"end":158},"obj":"CI"},{"id":"T27","span":{"begin":188,"end":202},"obj":"CI"},{"id":"T28","span":{"begin":243,"end":256},"obj":"CI"},{"id":"T29","span":{"begin":286,"end":299},"obj":"CI"}],"text":"We conducted a 32-week, double-blind, placebo-controlled, cross-over and randomized trial that implicated two arms: arm A, 20 patients received levocetirizine, montelukast with or without levocetirizine or placebo; arm B, 20 patients received desloratadine, montelukast with or without desloratadine or placebo."}

{"project":"Linmchun_800_3","denotations":[{"id":"T4","span":{"begin":144,"end":158},"obj":"CI"},{"id":"T5","span":{"begin":160,"end":171},"obj":"CI"},{"id":"T6","span":{"begin":188,"end":202},"obj":"CI"},{"id":"T7","span":{"begin":206,"end":213},"obj":"CI"},{"id":"T8","span":{"begin":243,"end":256},"obj":"CI"},{"id":"T9","span":{"begin":258,"end":269},"obj":"CI"},{"id":"T10","span":{"begin":286,"end":299},"obj":"CI"},{"id":"T11","span":{"begin":303,"end":310},"obj":"CI"}],"text":"We conducted a 32-week, double-blind, placebo-controlled, cross-over and randomized trial that implicated two arms: arm A, 20 patients received levocetirizine, montelukast with or without levocetirizine or placebo; arm B, 20 patients received desloratadine, montelukast with or without desloratadine or placebo."}